Founded in 2017 by experts in medicine and data science, Oxipit is a leader in AI-driven medical imaging. In 2019, the company received CE certification for ChestEye, its CAD solution that detects 75 chest X-ray findings and provides image annotations. Oxipit later introduced ChestEye Quality, which delivers real-time quality assurance for radiology workflows. Building on this success, the company launched ChestLink in April 2022—the world’s first CE Class IIb-certified autonomous AI imaging application—capable of identifying normal chest X-ray studies with 99.9% sensitivity. Today, these solutions form the Oxipit CXR Suite – a comprehensive portfolio that spans CAD, quality assurance, and autonomous healthy CXR reporting. By automating routine cases and providing real-time support, Oxipit empowers radiologists to focus on complex and high-priority studies, ensuring consistent diagnostics and better patient outcomes. Trusted by healthcare providers worldwide, Oxipit continues to advance AI-powered radiology, shaping the future of medical imaging.
